首页> 外文期刊>Orbit >Evisceration with autogenous scleral graft and bioceramic implantation within the modified scleral shell: 133 cases over 17?years
【24h】

Evisceration with autogenous scleral graft and bioceramic implantation within the modified scleral shell: 133 cases over 17?years

机译:在改良的巩膜外壳内具有自体巩膜移植物和生物陶瓷植入的展示:133例超过17?年

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: To present long-term follow-up data on evisceration performed with autogenous scleral grafting and ceramic implantation in a modified scleral shell.Methods: This was a retrospective analysis of all consecutive eviscerations performed in the Department of Ophthalmology, Montpellier University Hospital, France, between February 1998 and October 2015. For all patients, the technique used was a conventional anterior evisceration after total keratectomy, disinsertion of the medial rectus muscle, sectioning of the optic nerve and excision of sclera centered on the papilla. The scleral graft was then sutured just behind the sutured keratectomy, and the bioceramic implant was inserted by posterior way in the scleral shell. Demographic characteristics, implant size and type, cosmetic results from pictures of all patients and complications were recorded. This study was performed with Ethics Review Committee Approval, and in compliance with the Declaration of Helsinki.Results: In total, 133 patients (36.6% women) were identified during the study period. The mean (SD) implant size was 17.32 (1.84) mm. The median follow-up after evisceration was 57.43 (24.7, 68.3) months. Two cases of implant exposure (1.5%) were recorded. For 24 patients (17.9%), additional surgeries were performed for ptosis (2.2%), conjunctival cyst (1.5%), or post-evisceration socket syndrome (6.7%). Cosmetics results were excellent for 50.1% of cases, good for 33.3% and fair for 16.6%; using a grading scale based on the superior sulcus deformity.Conclusion: Evisceration with autogenous scleral grafting and ceramic implantation can result in a high volume of restoration, good cosmetic results, and low risk of exposure of the implant.
机译:介绍:在改进的SCLERAL SHERCH中,目前对凹陷的长期后续数据进行了剥离和陶瓷植入。 ,1998年2月和2015年10月。对于所有患者,所用的技术是常规的术后角膜切除术后的常规凹凸,内侧直肠肌肉灭菌,切割视神经和巩膜上的切除在乳头上。然后将巩膜移植物缝合在缝线角膜切除术后,并且通过巩膜壳的后陶瓷植入物插入。记录了所有患者和并发症的图片的人口特征,种植体大小和类型,化妆品结果。本研究进行了伦理审查委员会批准,并遵守赫尔辛基的宣言。结果:在研究期间,鉴定了133名患者(36.6%的妇女)。平均值(SD)植入物尺寸为17.32(1.84)mm。展示后的中位后续行动为57.43(24.7,68.3)个月。记录了两种植入暴露(1.5%)。对于24名患者(17.9%),对角症(2.2%),结膜囊肿(1.5%)或后颌骨综合征(6.7%)进行额外的手术。化妆品效果均为50.1%的病例,良好33.3%,公平为16.6%;使用基于卓越的硫磺畸形的分级秤。结论:具有自动巩膜嫁接和陶瓷植入的展示可导致恢复量高,良好的美容结果和植入暴露的低风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号